Assessment of infectivity and the impact on neutralizing activity of immune sera of the COVID-19 variant, CAL.20C
Main Authors: | Zhongcheng Zhou, Peng Du, Meixing Yu, Daniel T. Baptista-Hon, Man Miao, Andy P. Xiang, Johnson Yiu-Nam Lau, COVID-19 Immunity Investigation Group, Gen Li, Kang Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-07-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-021-00695-0 |
Similar Items
-
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants
by: Satoshi Ikegame, et al.
Published: (2021-07-01) -
Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody
by: Shuai Yue, et al.
Published: (2021-09-01) -
Myomedin scaffold variants targeted to 10E8 HIV-1 broadly neutralizing antibody mimic gp41 epitope and elicit HIV-1 virus-neutralizing sera in mice
by: Milan Kuchař, et al.
Published: (2021-01-01) -
Neutralization of EBV DNA polymerase activity with sera from nasopharyngeal carcinoma patients
by: ZHOU, WEN-XIANG, et al.
Published: (1987) -
Proteins mimicking epitope of HIV-1 virus neutralizing antibody induce virus-neutralizing sera in miceResearch in context
by: Petr Kosztyu, et al.
Published: (2019-09-01)